wellrank.ai
Sign In
Novo Nordisk logo

Novo Nordisk

First cited by AI Jun 11, 2026
novonordisk.com

Surfaced organically in AI answers about glp-1 weight loss. Not yet profiled.

AI Visibility

Visibility trend

Compounded GLP-1s, daily share of AI answers mentioning Novo Nordisk, through Jul 29, 2026.

31.3%

Avg position when mentioned: 2.7 · peak 40% on Jul 9

By engine

Where Novo Nordisk is strong, and where it is invisible.

  • ChatGPT
    58.3%
  • Claude
    33.3%
  • Google AI
    33.3%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 298 positive mentions
  • 330 neutral
  • 2 mixed or cautious

Recent AI answers mentioning Novo Nordisk

ChatGPTJul 29, 2026, 09:44 UTC
How can I tell if an online compounded semaglutide pharmacy is FDA compliant?

Short answer: there is no single “FDA stamp” for retail compounding pharmacies. The FDA regulates drugs and outsourcing facilities (503B) and inspects them, but most compounding pharmacies (503A) are regulated primarily by state boards and must follow USP sterile-compounding standards. To judge whether an online compounder of semaglutide is operating safely and lawfully, use the checklist below. What to check (practical checklist) Do they require a valid prescription from a U.S.-licensed prescriber? Red flag: they will sell injectable semaglutide without a prescription or with only an online questionnaire and no licensed prescriber identified. Are they a 503B outsourcing facility (FDA-regulated)? 503B facilities register with the FDA and are subject to cGMP and FDA inspections. Ask whether they are registered as an FDA “outsourcing facility” and verify on the FDA’s list of registered outsourcing facilities. If they are a 503A compounding pharmacy (state-regulated), are they licensed in your state and in good standing? Lookup the pharmacy on your state Board of Pharmacy website and ask for the pharmacy license number and last inspection date. Do they have third-party accreditation? Look for NABP VIPPS (Verified Internet Pharmacy Practice Sites) or compounding accreditations from organizations such as ACHC or URAC. Accreditation isn’t required but is a good sign. Do they follow USP standards and provide sterility/potency testing? Ask for proof they follow USP <797>/<800> (sterile compounding). For each lot request batch-specific Certificates of Analysis (CoA) and independent lab test results for potency, sterility and endotoxin for the injection lot you’ll receive. What is their API (active pharmaceutical ingredient) source and testing? Ask whether they compound from an FDA-approved finished product or from bulk API. Compounding a copy of an FDA‑approved drug or compounding from unapproved bulk API raises regulatory and safety issues; reputable pharmacies should disclose the API supplier and provide CoAs. Cold chain and shipping For injectable semaglutide you should see validated cold-chain packaging, tracking, and temperature-monitoring procedures. Transparency and policies They should publish an adverse-event reporting procedure, recall policy, physician contact information, and a physical pharmacy address (not just a PO box). Check public records Search the FDA Enforcement Reports and your state Board of Pharmacy for warning letters, recalls, or disciplinary actions against the pharmacy. Search MedWatch for adverse-event reports. Regulatory context and important cautions Semaglutide is available as FDA‑approved products (Ozempic, Wegovy, Rybelsus by Novo Nordisk). The FDA has warned about compounding when an FDA‑approved product exists or when bulk drug substances are used without appropriate authorization. That means compounded semaglutide can be legally and clinically problematic. If you want the safety of an FDA‑approved product, ask your prescriber about Ozempic or Wegovy rather than a compounded alternative. For weight-loss/treatment options, also discuss other FDA-approved medications with your clinician (example brands: Novo Nordisk’s Wegovy/Ozempic; Eli Lilly’s Mounjaro is tirzepatide — not semaglutide — and has different regulatory status). For the highest regulatory oversight among compounders, prefer a 503B outsourcing facility (FDA-registered). If a pharmacy says “FDA compliant” be skeptical — ask what they mean and ask for the outsourcing-facility registration or inspection reports. Red flags (stop and verify) No prescription required. No physical address, opaque ownership, or offshore/unlicensed claims. No batch testing, no sterility/potency CoAs, or unwillingness to share API source. Claims that the compounded product is “FDA approved” (only drugs are FDA-approved, not pharmacies or compounded preparations). Extremely low price compared with legitimate pharmacies (could imply cutting corners). If you want, I can: Check a specific pharmacy or website (give me its name/URL) and walk through what to verify and what public records to search. Help draft an email to the pharmacy requesting license numbers, CoAs, 503B registration (if any), sterility testing, and shipping validation.

Mentioned in position 1 of 2

Read full answer with sources →
ClaudeJul 29, 2026, 09:44 UTC
My compounded semaglutide provider shut down. Where should I move my treatment?

Moving Your Compounded Semaglutide Treatment This is a common situation right now given FDA and regulatory changes. Here are your main options: Branded GLP-1 Medications (Most Reliable Path) Novo Nordisk's Ozempic/Wegovy - The original semaglutide. Talk to your regular doctor or endocrinologist about a prescription. Wegovy is specifically FDA-approved for weight loss. Eli Lilly's Zepbound/Mounjaro - Tirzepatide, often considered equally or more effective for weight loss, widely available now Telehealth Platforms Offering Licensed Options Hims & Hers - Now offers branded semaglutide and tirzepatide options Ro (Roman) - Offers Wegovy and other branded GLP-1s with medical support Calibrate - Focuses on metabolic health with GLP-1 prescriptions Found - Telehealth weight loss with multiple medication options Practical Tips Check your insurance - Wegovy/Zepbound coverage has improved Use manufacturer savings cards - Novo Nordisk and Lilly offer programs that can significantly reduce cost Ask about samples from your primary care doctor to bridge gaps Key Consideration Branded medications have consistent dosing and FDA oversight, which is actually an advantage over compounded versions. Would you like more detail on cost, insurance, or any specific option?

Mentioned in position 1 of 6

Read full answer with sources →
ChatGPTJul 29, 2026, 09:43 UTC
My insurance denied Wegovy. Are compounded GLP-1s my best option?

Short answer: usually no — compounded GLP‑1s are generally a last-resort option because they carry safety, quality and legal risks. Before you consider compounding, try other, safer and often less risky routes. What to try first Appeal the denial. Ask your prescriber to submit a prior authorization or a letter of medical necessity (peer-to‑peer review can help). Many denials are reversed on appeal. Contact the manufacturer. Novo Nordisk offers Wegovy patient support and savings programs that can reduce out‑of‑pocket cost for commercially insured patients and has patient assistance resources for qualifying people. Check other FDA‑approved weight‑loss drugs your insurer may cover: Saxenda (liraglutide), Qsymia (phentermine/topiramate), Contrave (bupropion/naltrexone), or Zepbound (tirzepatide) — coverage varies, but one of these may be covered where Wegovy was not. If you have type 2 diabetes, discuss GLP‑1s or tirzepatide prescribed for diabetes (Ozempic, Mounjaro) — insurers more often cover them for diabetes, and they also cause weight loss (but use and dosing should be guided by your clinician). Look into manufacturer savings/coupon sites and discount services to lower cash price: Novo Nordisk patient support for Wegovy, and tools such as GoodRx or Blink Health can sometimes reduce out‑of‑pocket cost (coupons aren’t valid for all payers and not for Medicare/Medicaid). If you consider other care routes See an obesity medicine specialist (ABOM‑certified) or endocrinologist — they can help with appeals, alternative prescriptions, or programmatic weight‑management options (medical clinics, academic centers, bariatric surgery evaluation if appropriate). Consider clinical trials for weight‑loss medications at academic centers if eligible. About compounded GLP‑1s — what you need to know Compounded GLP‑1 peptides (semaglutide/tirzepatide made by compounding pharmacies) are not FDA‑approved products. That means no standard FDA oversight of manufacturing, potency, sterility, and purity. Known risks: inconsistent dose/potency, contamination/sterility failures (risk of infection), unknown source of active peptide, no guaranteed cold‑chain or stability data, and limited post‑market safety reporting. Some states or pharmacy boards restrict compounding of certain biological peptides; large insurers and many health systems will not accept prescriptions for compounded biologics. If you still consider a compounded product (only after exhausting safer options), only use a reputable sterile compounding pharmacy that: Provides certificates of analysis and sterility testing, Is accredited (ask about USP <797>/USP <800> compliance and membership/affiliation with PCCA or similar), Will disclose source of active ingredients and compounding protocols, Has clear counseling on storage, handling and returns, And get explicit informed-consent documentation from your prescriber about risks. Where to look for help (specific names) Novo Nordisk Wegovy patient support/savings — contact the manufacturer for assistance and eligibility for savings or patient assistance. GoodRx or Blink Health — price comparison and coupons for cash pay options (verify which payers they work with). ABOM Directory (American Board of Obesity Medicine) — to find an obesity medicine specialist near you who can help with appeals and alternative care. Local academic weight‑management or bariatric centers — for multidisciplinary care and access to clinical trials. If you consider compounding, ask your clinician for referrals to a reputable compounding pharmacy and verify USP/PCCA/board credentials. Bottom line Compounded GLP‑1s are not the best general option because of safety and quality concerns. First pursue an appeal, manufacturer assistance, covered alternative medications, or specialist care. If after careful consideration and informed consent you still consider a compounded product, only use a highly reputable sterile compounding pharmacy and discuss risks with your prescriber. If you want, tell me: (1) whether you have diabetes or other medical issues, (2) whether you have commercial insurance vs Medicare/Medicaid, and (3) whether you want help drafting an appeal letter or locating a nearby ABOM specialist — I can help with the next step.

Mentioned in position 1 of 9

Read full answer with sources →
ClaudeJul 29, 2026, 09:43 UTC
My insurance denied Wegovy. Are compounded GLP-1s my best option?

This is a really common situation right now. Here are some honest options to consider: Compounded GLP-1s - Legitimate but with caveats Hims & Hers, Ro, and eMD offer compounded semaglutide These can be significantly cheaper ($200-400/month vs $1,300+) Important: The FDA recently signaled it may restrict these as Wegovy shortages resolve, so availability may change Quality varies - stick to 503B-registered compounding pharmacies Direct Manufacturer Programs Novo Nordisk's savings card can reduce Wegovy to ~$650/month for commercially insured patients Their Patient Assistance Program may cover it if you meet income requirements Consider Appealing Your Denial Ask your doctor to submit a prior authorization appeal with documentation of health conditions A formal denial letter gives you appeal rights - this works more often than people expect Alternative Covered Medications Ozempic (same drug, diabetes indication) is sometimes easier to get covered Zepbound (tirzepatide) may have different coverage on your plan What I'd Suggest First Call your doctor's office and ask them to appeal AND contact Novo Nordisk directly about assistance programs before going the compounded route. Would you like more detail on any of these paths?

Mentioned in position 4 of 4

Read full answer with sources →
ChatGPTJul 29, 2026, 09:42 UTC
What red flags should I watch for with online Ozempic sellers?

Short answer: treat any seller that avoids a prescription, is unusually cheap, won’t show lot/expiry/manufacturer info, or can’t prove it’s a licensed pharmacy as high risk. There have been many counterfeit, mishandled, or otherwise unsafe semaglutide (Ozempic) products sold online. Red flags to watch for No prescription required or very quick “prescription” with no medical review. Legitimate prescribers require a history or telehealth visit. Seller refuses to provide the name of the manufacturer (Novo Nordisk for Ozempic) or the lot number and expiration date. Prices that are far below market — if it sounds too good to be true, it often is. Payment by wire transfer, cryptocurrency, gift cards, Zelle, or other untraceable methods. No licensed pharmacist contact, no pharmacy name, or no physical address/phone number you can verify. Sellers on social media, DMs, darknet marketplaces, classifieds or forums rather than a verified pharmacy platform. Lack of temperature-controlled shipping or vague shipping claims. Semaglutide pens require cold-chain handling — poor shipping can degrade the drug. Packaging that looks tampered, damaged, unbranded or missing patient information leaflets and dosing instructions. Offers to split pens, repackage doses, or sell individual syringes/ampoules that don’t match how the branded product is supplied. Overly positive reviews but no independent ratings or reports of negative experiences (fake reviews). Prescribers who will write large amounts with no follow-up or no documentation, or who pressure you to buy immediately. How to verify a seller Require a prescription and an opportunity to speak to a licensed clinician or pharmacist. Use pharmacies accredited by your national/state board or by the NABP (VIPPS accreditation) or a .pharmacy domain. Call the pharmacy’s phone number and ask to speak to the pharmacist; verify licensing with your state pharmacy board. Check packaging for the manufacturer (Novo Nordisk for Ozempic), lot number, and expiration date on the box and pen. Ask how they handle cold-chain shipping and how quickly they ship. Compare pricing with major pharmacies — large discrepancies are suspicious. Where to buy more safely (examples) Local or large chain pharmacies: CVS, Walgreens, Walmart, Rite Aid — they are licensed, offer refrigerated storage, and will fill prescriptions from your doctor. Reputable telehealth + pharmacy services that require clinicians and handle prescriptions, e.g. Hims & Hers (Hims/Hers) and Ro — they perform medical assessments and dispense through licensed pharmacies. (Confirm they offer semaglutide in your state and check current availability.) Use price-comparison/coupon services like GoodRx to reduce cost but still get medication from a licensed pharmacy. What to do if you suspect counterfeit or mishandled product Stop using it immediately. Save packaging, photos of the product, lot number, and any correspondence. Contact your prescriber or local pharmacist before using another dose. Report to FDA MedWatch (if in the U.S.) and to your state pharmacy board. Notify the drug manufacturer (Novo Nordisk) if possible. If you have symptoms of an adverse reaction (allergic reaction, unexpected blood sugar changes, infection at injection site), seek medical care right away. If you want, I can: Help you verify a specific online seller (give me the URL, seller name, photos of packaging, or exact payment requests) and show what to check. Suggest steps to get a legitimate prescription or find local/online pharmacies that ship properly to your area.

Mentioned in position 1 of 8

Read full answer with sources →
ClaudeJul 29, 2026, 09:42 UTC
What red flags should I watch for with online Ozempic sellers?

Red Flags When Buying Ozempic Online Serious Warning Signs No prescription required Legitimate Ozempic always requires a valid prescription - any site selling without one is operating illegally Prices that seem too good to be true Authentic Ozempic is expensive (~$900+/month without insurance) - dramatic discounts often mean counterfeit product No licensed US pharmacy verification Look for NABP (.pharmacy) accreditation or state pharmacy board licensing Vague or overseas origins Unregulated foreign pharmacies may ship counterfeit or improperly stored medication No real pharmacist contact Legitimate pharmacies provide direct pharmacist consultation Legitimate Options to Consider Novo Nordisk's own patient resources at ozempic.com Mark Cuban's Cost Plus Drugs (costplusdrugs.com) for transparent pricing Hims/Hers, Ro, or Calibrate - telehealth platforms with licensed prescribers (note: may offer compounded semaglutide, which differs from brand-name Ozempic) Local retail pharmacies like CVS, Walgreens, or Costco with verified prescription Bottom Line The FDA has warned about counterfeit Ozempic in circulation. Stick to verifiable, licensed US pharmacies and always get a legitimate prescription from a real provider.

Mentioned in position 1 of 7

Read full answer with sources →

TL;DR

Novo Nordisk is a Danish pharmaceutical company best known for developing semaglutide-based medicines, including Ozempic and Wegovy, which sit at the center of the current GLP-1 weight-loss conversation. In WellRank's latest index, the brand ranks third in Compounded GLP-1s at 35% AI visibility, fourth in Wegovy queries at 32%, fifth in Ozempic queries at 22%, and sixth in GLP-1 weight loss broadly at 18%, making it one of the most consistently surfaced pharmaceutical manufacturers across AI-generated health answers.

Company Overview

Novo Nordisk is a global pharmaceutical company headquartered in Bagsvaerd, Denmark, founded in 1923. Its business model centers on developing, manufacturing, and commercializing prescription medicines, with a historical focus on diabetes care that has expanded significantly into obesity treatment. The company operates across more than 80 countries and sells its products through pharmacies, healthcare providers, and patient-assistance programs.

Product Features

  • Ozempic (semaglutide injection), approved for type 2 diabetes management
  • Wegovy (semaglutide injection at higher dose), approved for chronic weight management
  • Rybelsus (oral semaglutide), the first oral GLP-1 receptor agonist for type 2 diabetes
  • NovoCare patient-assistance and savings programs for eligible patients
  • Victoza (liraglutide), an earlier GLP-1 therapy for type 2 diabetes

Target Market

Novo Nordisk primarily serves adults with type 2 diabetes and adults with obesity or overweight with at least one weight-related condition, as defined by the approved indications for its medicines. Its products are prescribed across the United States, Europe, and other major markets through licensed healthcare providers and dispensed at retail and specialty pharmacies.

Buyer Personas

  • An adult with type 2 diabetes seeking a once-weekly injectable that also supports cardiovascular health, prescribed Ozempic by an endocrinologist or primary care physician.
  • A person with obesity who qualifies for Wegovy and is working with a doctor on a long-term weight-management plan.
  • A cost-sensitive patient using NovoCare savings resources or researching what Ozempic's list price actually means before filling a prescription.
  • A telehealth or virtual-care patient who encountered Novo Nordisk drugs through an online weight-loss program and wants to understand branded versus compounded options.

Funding & Performance

Novo Nordisk is a publicly traded company listed on Nasdaq Copenhagen and as an ADR on the New York Stock Exchange under the ticker NVO. It is one of the largest companies in Europe by market capitalization, though precise current figures fluctuate and should be verified through current financial sources. Specific revenue breakdowns by product line are reported in the company's public earnings disclosures.

Recent Developments

Novo Nordisk has expanded access to Wegovy through partnerships with retail pharmacy chains, including a presence on Walgreens virtual weight-loss pathways, and has been active in defending the branded semaglutide market as compounded versions drew regulatory scrutiny. The FDA has raised concerns about unapproved compounded GLP-1 drugs, a development that directly affects how Novo Nordisk's branded products are positioned. The company is also widely reported to be advancing next-generation obesity and cardiometabolic pipeline candidates.

Competitive Landscape

In AI-generated answers, Novo Nordisk is most frequently co-mentioned with Eli Lilly, its closest pharmaceutical rival and maker of tirzepatide-based drugs Mounjaro and Zepbound. It also appears alongside telehealth and pharmacy platforms including Hims and Hers, Ro, PlushCare, GoodRx, SingleCare, Walgreens, and CVS, reflecting the layered ecosystem of prescribers, compounders, and price-comparison services that orbit its branded drugs. Coverage comparing branded and compounded semaglutide, such as this breakdown of compounded versus branded GLP-1s, consistently places Novo Nordisk products as the reference standard.

Novo Nordisk vs the brands AI recommends alongside it

The real competitive set in Compounded GLP-1s: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Novo Nordisk logo
Novo NordiskThis brand
#3
31.3%
Hims & Hers logo
Hims & Hers

312 shared answers

#1
33.3%
Ro logo
Ro

297 shared answers

#2
33.3%
GoodRx logo
GoodRx

286 shared answers

#6
12.5%
PlushCare logo
PlushCare

174 shared answers

#10
10.4%

Email me when overtakes Novo Nordisk

One email the day the ranks flip. Nothing else.

User Sentiment

Of the 443 AI-engine mentions tracked by WellRank, 224 are positive and 219 are neutral, with zero mixed or cautious mentions, suggesting that AI systems treat Novo Nordisk primarily as an authoritative, factual reference rather than a source of controversy. Public and patient sentiment, as reflected in sources like WeightWatchers' Ozempic cost overview and community discussions, tends to focus on affordability and access rather than product efficacy, which is broadly accepted. The brand's tone in AI answers skews informational and clinical.

Pricing

Ozempic and Wegovy carry high list prices that are not publicly fixed in a simple way and vary by dose, pharmacy, and insurance coverage. Patients with commercial insurance may pay as little as the amount covered by Novo Nordisk savings cards, while uninsured patients face significantly higher out-of-pocket costs. Pricing details are explored in sources such as this GoodRx compounded semaglutide comparison and Healthline's guide to getting a Wegovy prescription online; exact current prices vary and should be confirmed at point of purchase.

Sources cited around Novo Nordisk

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Novo Nordisk weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Novo Nordisk? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.